Literature DB >> 8660664

Protein inhibitor of mitochondrial ATP synthase: relationship of inhibitor structure to pH-dependent regulation.

M S Lebowitz1, P L Pedersen.   

Abstract

In the absence of an electrochemical proton gradient, the F1 moiety of the mitochondrial ATP synthase catalyzes the hydrolysis of ATP. This reaction is inhibited by a natural protein inhibitor, in a process characterized by an increase in ATPase inhibition as pH is decreased from 8.0 to 6.0. In order to gain greater insight into the molecular and chemical events underlying this regulatory process, the relationships among pH, helicity of the inhibitor protein, and its capacity to inhibit F1-ATPase activity were examined. First, peptides corresponding to four regions of the 82-amino-acid inhibitor protein were chemically synthesized and assessed for both retention of secondary structure, and capacity to inhibit F1-ATPase activity. These studies showed that a region of only 24-amino-acid residues, from Phe 22 through Len 45, accounts for the inhibitory capacity of the inhibitor protein, and that retention of native helical structure in this region is not essential for inhibition. Second, three mutants (33P34, 39P40, and 43P44) of the intact inhibitor protein were prepared in which a proline residue was inserted within the inhibitory region to disrupt native helical structure. The secondary structures and inhibitory capacities of these mutants were analyzed as a function of pH. These studies revealed that, despite the initial loss of helical structure within the inhibitory region due to proline insertion, a further loss of helical structure is required to modulate inhibitory activity. These results suggest that a loss of helical structure outside the inhibitory region correlates with an increase in inhibitory capacity. Finally, two separate mutants (H48A and H55A) were prepared in which a conserved histidine residue in the wild-type inhibitor protein was replaced with an alanine. The secondary structures and inhibitory capacities of these mutants were also investigated as a function of pH. Results indicated that, although histidine residues do not directly affect the inhibitory capacity of the protein, they are important for maintaining the inhibitor protein in an inactive form at high pH. Furthermore, these results show that loss in helical structure, although correlated with an increase in inhibitory capacity, is not essential for this function. These novel experiments are consistent with a model in which the inhibitor protein is envisioned as consisting of two regions, an inhibitory region and a regulatory region. It is suggested that reduction of pH allows for the protonation of a histidine residue blocking the interaction between the two regions, thus activating the inhibitory response. The pH reduction also correlates with a partial unfolding of the protein that may either cause or result from the loss of interaction between the two helices. This unfolding may be necessary for further optimization of inhibitor function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8660664     DOI: 10.1006/abbi.1996.0261

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  14 in total

Review 1.  The structural and functional connection between the catalytic and proton translocating sectors of the mitochondrial F1F0-ATP synthase.

Authors:  S Papa; F Zanotti; A Gaballo
Journal:  J Bioenerg Biomembr       Date:  2000-08       Impact factor: 2.945

Review 2.  Medicinal chemistry of ATP synthase: a potential drug target of dietary polyphenols and amphibian antimicrobial peptides.

Authors:  Zulfiqar Ahmad; Thomas F Laughlin
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

Review 3.  ATP synthase and the actions of inhibitors utilized to study its roles in human health, disease, and other scientific areas.

Authors:  Sangjin Hong; Peter L Pedersen
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

4.  Differential display analysis of murine collagen-induced arthritis: cloning of the cDNA-encoding murine ATPase inhibitor.

Authors:  E Yamada; N Ishiguro; O Miyaishi; A Takeuchi; I Nakashima; H Iwata; K Isobe
Journal:  Immunology       Date:  1997-12       Impact factor: 7.397

Review 5.  ATP synthase: a molecular therapeutic drug target for antimicrobial and antitumor peptides.

Authors:  Zulfiqar Ahmad; Florence Okafor; Sofiya Azim; Thomas F Laughlin
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

6.  Are rod outer segment ATP-ase and ATP-synthase activity expression of the same protein?

Authors:  Daniela Calzia; Simona Candiani; Greta Garbarino; Federico Caicci; Silvia Ravera; Maurizio Bruschi; Lucia Manni; Alessandro Morelli; Carlo Enrico Traverso; Giovanni Candiano; Carlo Tacchetti; Isabella Panfoli
Journal:  Cell Mol Neurobiol       Date:  2013-04-09       Impact factor: 5.046

7.  Caenorhabditis elegans MAI-1 protein, which is similar to mitochondrial ATPase inhibitor (IF1), can inhibit yeast F0F1-ATPase but cannot be transported to yeast mitochondria.

Authors:  Naoki Ichikawa; Chiyoko Ando; Mina Fumino
Journal:  J Bioenerg Biomembr       Date:  2006-08-02       Impact factor: 2.945

8.  Cross-linking of the endogenous inhibitor protein (IF1) with rotor (gamma, epsilon) and stator (alpha) subunits of the mitochondrial ATP synthase.

Authors:  Fernando Minauro-Sanmiguel; Concepción Bravo; José J García
Journal:  J Bioenerg Biomembr       Date:  2002-12       Impact factor: 2.945

9.  Disruption of insulin signalling preserves bioenergetic competence of mitochondria in ageing Caenorhabditis elegans.

Authors:  Kristel Brys; Natascha Castelein; Filip Matthijssens; Jacques R Vanfleteren; Bart P Braeckman
Journal:  BMC Biol       Date:  2010-06-28       Impact factor: 7.431

10.  The serum- and glucocorticoid-induced protein kinase-1 (Sgk-1) mitochondria connection: identification of the IF-1 inhibitor of the F(1)F(0)-ATPase as a mitochondria-specific binding target and the stress-induced mitochondrial localization of endogenous Sgk-1.

Authors:  Bridget A O'Keeffe; Salvatore Cilia; Anita C Maiyar; Maria Vaysberg; Gary L Firestone
Journal:  Biochimie       Date:  2013-02-08       Impact factor: 4.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.